Business description
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life. Not only is the company a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B3 compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens. Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities.
Management board & Supervisory board
| CEO |
| Wolfgang Wienand |
| Management board |
| Philippe Deecke, Gordon Bates, Jean-Christophe Hyvert, Maria Soler Nunez, Christian Seufert, Daniel Palmacci |
| Supervisory board |
| Jean-Marc Huët, Juergen B. Steinemann, Angelica Kohlmann, Barbara M. Richmond, Christoph Mäder, Olivier Verscheure, Roger Nitsch, Marion Helmes |
Company data
| Name: |
Lonza Group AG |
| Address: |
Münchensteinerstraße 38,Basel |
| Phone: |
+41-61-31681-11 |
| Fax: |
+41-61-31691-11 |
| E-mail: |
info@lonza.com
|
| Internet: |
www.lonzagroup.com/ |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
31/12 |
| Free Float: |
99.70% |
| IPO date: |
02/11/1999 |
